
A health insurance claims-based risk assessment tool to predict patients’ first severe chronic obstructive pulmonary disease exacerbation has been developed and validated.
A health insurance claims-based risk assessment tool to predict patients’ first severe chronic obstructive pulmonary disease exacerbation has been developed and validated.
The ratio of controller to total asthma medications can be calculated using 1 or 2 quarters of data; high versus low ratios differentiate patient characteristics.
Asthma-specific quality of life and a history of acute episodes can be used together to identify risks of subsequent acute exacerbations.
Published: February 17th 2018 | Updated:
Published: December 1st 2007 | Updated:
Published: April 15th 2008 | Updated:
Published: March 9th 2010 | Updated:
Published: October 1st 2005 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.